Merck, BGI Team on Biomarker Discovery | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Merck and BGI announced today that they will collaborate on the discovery and development of biomarkers and other genomic technologies.

The alliance combines Merck's expertise in drug discovery and development with BGI's sequencing and analytical capabilities.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.